Novo Nordisk (NVO)
(Delayed Data from NYSE)
$131.54 USD
+1.55 (1.19%)
Updated Jul 19, 2024 04:00 PM ET
After-Market: $131.58 +0.04 (0.03%) 7:58 PM ET
3-Hold of 5 3
C Value A Growth B Momentum B VGM
Industry / Sector Report
Industry : Large Cap Pharmaceuticals
Zacks Industry Rank
Bottom 28% (181 out of 250)Zacks Sector Rank
Top 25% (4 out of 16)Recommendations and Estimates
Company | Industry | SP500 | |
---|---|---|---|
Average Recommendation (1=Buy, 5=Sell) | 1.58 | 2.10 | 9.99 |
Current Quarter Estimate | 0.76 | 37.64 | 61.00 |
Year Ago Quarter Estimate | 0.63 | 11.39 | 54.84 |
Next Quarter Estimate | 0.94 | 34.85 | 63.00 |
Next Year Estimate | 4.35 | 178.47 | 270.00 |
Growth Rates
Company | Industry | SP500 | |
---|---|---|---|
This Year | 25.19 | -0.90 | 15.67 |
Next Year | 28.70 | 15.80 | 9.31 |
Last 5 Years | 17.00 | 2.90 | 8.10 |
Next 5 Years | 29.40 | 12.70 | NA |
Financials
Company | Industry | |
---|---|---|
Price/Earnings (TTM) | 45.36 | 15.53 |
Price/Book (MRQ) | 40.99 | 6.15 |
Price/Cash Flow (MRFY) | 43.69 | 10.87 |
Dividend Yield | 1.01% | 2.39% |
Net Profit Margin (TTM) | 36.56% | NA |
Return on Equity (TTM) | 91.70% | NA |
Debt to Equity (MRQ) | NA | NA |
MRQ = Most Recent Quarter
TTM = Trailing Twelve Months
MRFY = Most Recent Fiscal Year
Note: Company and S&P 500 ratios relating to share price calculated daily; all others calculated weekly or in accordance with company earnings announcement. Industry medians calculated weekly.